- Home
- APVO vs PSHG Comparison
APVO vs PSHG Comparison
Compare APVO & PSHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APVO
- PSHG
- Stock Information
- Founded
- APVO 2016
- PSHG 2010
- Country
- APVO United States
- PSHG Greece
- Employees
- APVO N/A
- PSHG N/A
- Industry
- APVO Biotechnology: Pharmaceutical Preparations
- PSHG Marine Transportation
- Sector
- APVO Health Care
- PSHG Consumer Discretionary
- Exchange
- APVO Nasdaq
- PSHG Nasdaq
- Market Cap
- APVO 21.7M
- PSHG 25.2M
- IPO Year
- APVO N/A
- PSHG N/A
- Fundamental
- Price
- APVO $1.46
- PSHG $2.00
- Analyst Decision
- APVO
- PSHG
- Analyst Count
- APVO 0
- PSHG 0
- Target Price
- APVO N/A
- PSHG N/A
- AVG Volume (30 Days)
- APVO 4.5M
- PSHG 125.2K
- Earning Date
- APVO 11-10-2025
- PSHG 11-07-2025
- Dividend Yield
- APVO N/A
- PSHG N/A
- EPS Growth
- APVO N/A
- PSHG 5.84
- EPS
- APVO N/A
- PSHG 1.56
- Revenue
- APVO N/A
- PSHG $84,042,000.00
- Revenue This Year
- APVO N/A
- PSHG N/A
- Revenue Next Year
- APVO N/A
- PSHG $17.95
- P/E Ratio
- APVO N/A
- PSHG $1.29
- Revenue Growth
- APVO N/A
- PSHG N/A
- 52 Week Low
- APVO $1.32
- PSHG $1.31
- 52 Week High
- APVO $298.00
- PSHG $2.34
- Technical
- Relative Strength Index (RSI)
- APVO 42.13
- PSHG 59.11
- Support Level
- APVO $1.48
- PSHG $1.98
- Resistance Level
- APVO $1.57
- PSHG $2.16
- Average True Range (ATR)
- APVO 0.09
- PSHG 0.09
- MACD
- APVO 0.00
- PSHG 0.01
- Stochastic Oscillator
- APVO 0.00
- PSHG 51.66
About APVO Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidates are; ALG.APV-527, which targets co-stimulatory receptors and tumor antigens, and CD3xCD123, which is being developed as a potential treatment of frontline acute myelogenous leukemia. The company's preclinical candidates, APVO711, APVO0442, and APVO603, are being developed using the ADAPTIR modular protein technology platform. The company's versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.
About PSHG Performance Shipping Inc.
Performance Shipping Inc is a provider of shipping transportation services through its ownership of tanker vessels. The company's vessels are employed on time charters with liner companies carrying containerized cargo along various shipping routes. It owns and operates six Aframax tanker vessels.